Search results
Personalis Inc. executive sells over $6,500 in company stock By Investing.com
Investing.com· 16 hours agoPersonalis, Inc. (NASDAQ:PSNL) has reported a recent transaction by Chief Medical Officer and EVP,...
Here’s Why RGAIA Considers Maravai LifeSciences Holdings’ (MRVI) Margin Structure as the Best
Insider Monkey via Yahoo Finance· 4 days agoRGA Investment Advisors, an investment management company released its first quarter 2024 investor...
Moderna stock is lone omen of bird flu pandemic
Reuters· 4 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Personalis executive sells over $2,000 in stock at $1.27-$1.29 range By Investing.com
Investing.com· 16 hours agoStephen Michael Moore, the Senior Vice President and Chief Legal Officer at Personalis, Inc....
Worried you missed the Nvidia bandwagon? Here are some alternative stocks.
MarketWatch via Yahoo Finance· 6 days agoENPH 33.2% 47.0% 32.9 28.0 -28% EQT...4% 84.8% 16.0 11.3 16% Nvidia Corp. NVDA 25.8% 26.1% 43.3 48.3...
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
Benzinga via Yahoo Finance· 7 days agoVaxart, Inc. (NASDAQ:VXRT) shares traded higher in the premarket session on Friday, up more than 23%...
Gateway - Quartz
Quartz· 3 days agoModerna stock jumped 7% during premarket trading on Thursday after the pharma company, known for its mRNA COVID-19 vaccine, reported a profit of $217 million ...
A Bird-Flu Pandemic in People? Here’s What It Might Look Like.
The New York Times via Yahoo News· 4 days agoThe bird flu outbreak in dairy cattle has so far spilled over to just three farmworkers in the...
B.Riley lifts Vaxart shares target on BARDA award By Investing.com
Investing.com· 7 days ago(NASDAQ:VXRT) shares to $2.50, up from the previous $2.00, while maintaining a Buy rating on the ...
Gateway - Quartz
Quartz· 3 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an early-phase clinical trial testing the combined use of an experimental cancer ...
